Pune, April 02, 2025 (GLOBE NEWSWIRE) -- Organ-on-a-Chip Market Size & Growth Analysis:
According to SNS Insider, The Organ-on-a-Chip Market was valued at USD 117.67 million in 2023 and is projected to reach USD 1,641.51 million by 2032, expanding at an impressive CAGR of 34.04% from 2024 to 2032.
This remarkable growth is propelled by the increasing need for more accurate and human-relevant drug testing models, advancements in microfluidics technology, and a global shift toward reducing animal testing in pharmaceutical research.
Get a Sample Report of Organ-on-a-Chip Market@ https://www.snsinsider.com/sample-request/5467
Market Overview
Organ-on-a-Chip technology is revolutionizing the landscape of drug discovery and development with its microengineered systems mimicking human organ function. OOC chips allow for the more accurate evaluation of drug efficacy and toxicity, thus maximizing preclinical predictive value. Adoption in the United States has been significant, with governmental agencies as well as private organizations investing heavily in OOC technology to speed up drug development procedures and reduce the use of animal models.
The increasing need for personalized medicine also increases the importance of OOC platforms. Through the generation of patient-specific organ models, such technologies promote the creation of personalized therapeutic approaches for chronic diseases, such as cancer and neurodegenerative diseases. Also, stringent regulation paradigms calling for alternative approaches for testing have hastened the implementation of OOC systems in different industries.
Key Organ-on-a-Chip Companies Profiled in the Report
- Emulate, Inc.
- MIMETAS B.V.
- Valo Health
- Nortis, Inc.
- AxoSim
- BICO
- CN Bio Innovations Ltd
- The Charles Stark Draper Laboratory, Inc.
- SynVivo, Inc.
- AlveoliX AG
Organ-on-a-Chip Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 117.67 million |
| Market Size by 2032 | US$ 1,641.51 million |
| CAGR | CAGR of 34.04% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segment Analysis
By Products & Services
The services segment led the market in 2023, accounting for 53% of the overall revenue share. This is due to the increasing trend among biotechnology and pharmaceutical firms to outsource specialized activities like custom chip design, consulting, and technical support. With OOC technologies becoming more complex, tapping external expertise enables these firms to concentrate on core research activities, thus improving efficiency and innovation.
Conversely, the products segment is anticipated to be the highest-growing during the forecast period. Ongoing innovations in microfabrication and cell culture methods are propelling the creation of more advanced OOC devices. The growing availability of standardized, ready-to-use chips is anticipated to drive the growth of this segment.
By Application
In terms of revenue, drug discovery made up 61% of the total in 2023 and was the leading application. The capability of OOC platforms to offer human-relevant models for preclinical testing has transformed the evaluation of drug efficacy and toxicity, lowering high clinical attrition rates.
The toxicology research area is expected to expand at the highest rate. OOC systems provide a more precise and ethical substitute for animal testing by mimicking human physiological reactions, enhancing the veracity of toxicity tests, and providing improved safety profiles for new drugs.
By End-Use
The pharmaceutical and biotechnology companies’ segment was the market leader in 2023, commanding a revenue share of 73%. OOC technologies are increasingly being incorporated by these organizations to speed up drug development processes, save costs, and enhance the reliability of preclinical testing results.
The most rapidly expanding end-use application is academic and research institutions. The use of OOC platforms in these institutions enables advanced disease modeling and basic research, enabling collaborations that spur innovation and broaden the scope of OOC technologies.
Need Any Customization Research on Organ-on-a-Chip Market, Enquire Now@ https://www.snsinsider.com/enquiry/5467
Organ-on-a-Chip Market Segmentation
By Products & Service
- Products
- Instrument
- Devices
- Liver-on-a-Chip
- Lung-on-a-Chip
- Intestine-on-a-Chip
- Kidney-on-a-Chip
- Heart-on-a-Chip
- Others
- Services
By Application
- Drug Discovery
- Toxicology Research
- Others
By Model Type
- Organ-based model
- Disease-based model
By Purpose
- Therapeutic purpose
- Research purpose
By End Use
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Regional Analysis
North America was the largest organ-on-chip market in 2023, with 51% of the total revenue. This dominance is fueled by high investments in biomedical research, the presence of prominent industry players, and favorable regulatory policies supporting the use of cutting-edge technologies. Efforts by institutions like the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) have also helped reinforce the position of the region's market.
The Asia-Pacific region is forecast to grow at the fastest rate in the forecast period. Some of the reasons behind this aggressive growth are elevated investments in healthcare infrastructure, a rising focus on pharma R&D, and an active strategy of embracing emerging medical technologies in markets such as Japan, China, and South Korea.
Recent Developments
- February 2025 – Oxford University spin-out OrganOx secured USD 142 million to support its expansion in the U.S. The technology of the company maintains donated organs with blood at normal body temperatures and has been used in more than 5,000 transplant procedures since 2021.
- March 2024 – Emulate Inc. worked with the FDA to create liver-on-chip models that can enhance drug toxicity testing protocols. The collaboration is intended to build standardized protocols for incorporating OOC technology into regulatory assessments.
- April 2024 – CN Bio raised USD 21 million in Series B funding from Bayland Capital and CN Innovations Holdings Ltd. The funds will be used to fuel product development and address growing demand for OOC solutions, driven by drug R&D advances and regulatory shifts like the US FDA Modernization Act 2.0.
- March 2024 – MIMETAS became part of the Centre for Animal-Free Biomedical Translation, a project backed by €124 million of Dutch National Growth Fund. The partnership is set to promote animal-free biomedical innovations.
- October 2024 – Scientists at the University of the Basque Country (UPV) created artificial skin based on OOC technology to discontinue animal testing for drug development. The breakthrough seeks to alleviate ethical issues and enhance the predictive power of preclinical studies.
Buy a Single-User PDF of Organ on a chip Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5467
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023.
6. Competitive Landscape
7. Organ on a chip Market by Products & Service
8. Organ on a chip Market by Application
9. Organ on a chip Market by Model Type
10. Organ on a chip Market by Purpose
11. Organ on a chip Market by End Use
12. Regional Analysis
13. Company Profiles
14. Use Cases and Best Practices
15. Conclusion
Access Complete Report Details of Organ on a chip Market Analysis & Outlook 2024-2032@ https://www.snsinsider.com/reports/organ-on-a-chip-market-5467
[For more information or need any customization research mail us at info@snsinsider.com]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
